News & Publications for:

Mark Sands

Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy

Posted on June 17, 2013

Reddy, A.S., Patel, J.R., Vogler, C., Klein, R.S., Sands, M.S.; (2013) PLoS ONE, 8 (6), art. no. e64647 Read More

Posted in: Axon Injury & Repair, Publications Faculty: ,

Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells

Posted on July 6, 2012

Young MA, Larson DE, Sun CW, George DR, Ding L, Miller CA, Lin L, Pawlik KM, Chen K, Fan X, Schmidt H, Kalicki-Veizer J, Cook LL, Swift GW, Demeter RT, Wendl MC, Sands MS, Mardis ER, Wilson RK, Townes TM, Ley TJ (2012). Cell Stem Cell, 10(5):570-82 Read More

Posted in: Publications Faculty:

Mark Sands identifies combination treatment in mouse model of Batten disease

Posted on April 18, 2012

Gene therapy combined with bone marrow transplant synergizes to provide benefit in mouse model of this fatal childhood disease. Read More

Posted in: News Faculty:

Researchers identify gene for rare dementia

Posted on December 16, 2011

Cruchaga and colleagues identify DNAJC5 variants in Kufs disease, a neurodegenerative disorder in the neuronal ceroid lipofuscinoses (NCL) family. Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, News, Pilot Projects Faculty: , , ,

Bone marrow transplantation augments the effect of brain- and spinal cord-directed AAV2/5 gene therapy by altering inflammation in the murine model of globoid cell leukodystrophy

Posted on October 13, 2011

Reddy AS, Kim JH, Hawkins-Salsbury JA, Macauley SL, Tracy ET, Vogler CA, Han X, Song SK, Wozniak DF, Fowler SC, Klein RS, Sands MS (2011). J Neurosci, 31(27):9945-57
Read More

Posted in: Axon Injury & Repair, Neurovascular Injury & Repair, Publications, Therapeutics & Diagnostics Faculty: , , ,